Checkpoint Therapeutics, Inc.
Overview
Checkpoint Therapeutics, Inc. is a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Checkpoint Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.